LOC642852 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.734000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.284600E-01
Normal-vs-Stage2
3.694800E-01
Normal-vs-Stage3
5.178200E-02
Normal-vs-Stage4
8.492400E-01
Stage1-vs-Stage2
1.625550E-01
Stage1-vs-Stage3
5.881900E-02
Stage1-vs-Stage4
7.615400E-01
Stage2-vs-Stage3
2.521800E-01
Stage2-vs-Stage4
4.558800E-01
Stage3-vs-Stage4
1.401610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.488600E-01
Normal-vs-AfricanAmerican
7.871600E-01
Normal-vs-Asian
9.286300E-02
Caucasian-vs-AfricanAmerican
3.668200E-01
Caucasian-vs-Asian
9.149800E-02
AfricanAmerican-vs-Asian
1.969950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.193000E-01
Normal-vs-Female
4.646400E-01
Male-vs-Female
3.719400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.114600E-01
Normal-vs-Age(41-60Yrs)
5.453000E-01
Normal-vs-Age(61-80Yrs)
3.342800E-01
Normal-vs-Age(81-100Yrs)
1.946570E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.485000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.947200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.409200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.864200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.162020E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.633800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.167200E-01
Normal-vs-Daily Drinker
3.475400E-01
Normal-vs-Weekly Drinker
2.175600E-01
Normal-vs-Occasional Drinker
2.743000E-01
Normal-vs-Social Drinker
8.585600E-01
Non Drinker-vs-Daily Drinker
6.992200E-01
Non Drinker-vs-Weekly Drinker
8.807200E-01
Non Drinker-vs-Occasional Drinker
9.526800E-01
Non Drinker-vs-Social Drinker
1.035360E-01
Daily Drinker-vs-Weekly Drinker
6.102800E-01
Daily Drinker-vs-Occasional Drinker
6.915400E-01
Daily Drinker-vs-Social Drinker
1.049390E-01
Weekly Drinker-vs-Occasional Drinker
9.214000E-01
Weekly Drinker-vs-Social Drinker
1.258210E-01
Occasional Drinker-vs-Social Drinker
1.142440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.891200E-01
Normal-vs-Grade 2
4.542800E-01
Normal-vs-Grade 3
3.559000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.728000E-01
Grade 1-vs-Grade 3
2.358200E-01
Grade 1-vs-Grade 4
5.891200E-01
Grade 2-vs-Grade 3
5.071600E-01
Grade 2-vs-Grade 4
4.542800E-01
Grade 3-vs-Grade 4
3.559000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.193750E-01
Normal-vs-NonDiabetic
3.977600E-01
Diabetic-vs-NonDiabetic
1.059150E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.044600E-01
Normal-vs-NoPancreatitis
2.679400E-01
Pancreatitis-vs-NoPancreatitis
3.504400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.706000E-01
Normal-vs-N1
4.286200E-01
N0-vs-N1
3.896200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.510800E-01
Normal-vs-TP53-NonMutant
4.675400E-01
TP53-Mutant-vs-TP53-NonMutant
8.300600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
